Biographical summary
Elisa J.F. Houwink, M.D., Ph.D., is a Consultant with a joint appointment in the Department of Family Medicine and the Department of Clinical Genomics at Mayo Clinic in Rochester, Minnesota. Dr. Houwink provides primary care that integrates clinical genomics into everyday practice. Her work focuses on identifying inherited and rare conditions early and using personalized medicine — including pharmacogenomics — to improve medication safety and preventive care for individuals and families.
Dr. Houwink combines comprehensive family medicine with advanced genetic risk assessment, offering continuity of care that bridges traditional primary care and precision medicine.
She believes in caring for the whole patient and their family: using genetics and personalized medicine not as an add-on, but as a practical tool woven into routine care, helping people get ahead of disease before it becomes a crisis.
Areas of expertise
Dr. Houwink provides whole-person care that integrates family medicine and genomics, with a focus on prevention and personalized treatment. Her clinical interests include:
- Familial hypercholesterolemia and genetic cardiovascular risk: Assessment, early detection, and preventive strategies to reduce inherited heart disease risk
- Hemoglobinopathies: Screening and counseling for conditions such as sickle cell trait/disease and thalassemia within primary care
- Pharmacogenomic safety: Testing and interpretation for drug-gene interactions involving psychiatric medications, statins, and other commonly prescribed drugs
- Rare and undiagnosed genetic conditions: Integration of genomic insights into primary care evaluation and follow-up
- Genetic risk assessment: Family-history-based screening and cascade testing to help relatives understand and reduce disease risk
- Pharmacogenomic-guided prescribing: Applying genomic data to optimize medication choice and dosing for patient safety
- Comprehensive family medicine: Preventive and chronic care integrated with clinical genomics consultation and contraceptive services including Nexplanon placement
Research and expertise
Dr. Houwink is an Associate Professor of Family Medicine at Mayo Clinic College of Medicine and Science. Her research centers on the practical implementation of genomics and pharmacogenomics in primary care, including family-based cascade testing for cardiovascular and cancer risk, hemoglobinopathy screening strategies, and AI-supported identification of rare genetic conditions. She has presented extensively at North American Primary Care Research Group (NAPCRG) meetings on topics such as prescribing safety, genetic risk stratification, and early diagnosis of inherited conditions. Her work reflects a commitment to education, quality improvement, and innovation to make precision medicine accessible in everyday practice.
Personal note
Dr. Houwink is passionate about living an active lifestyle and finds balance through rowing, triathlon training, yoga, and outdoor adventures with her husband, Bas. She deeply values family time with her two children, Marieke and Joppe, and is committed to giving back through volunteer initiatives supporting community health and well-being.
Interests
- My clinical interests are very broad for I am truly passionate about Family Medicine, seeing patients from birth to end of life. But of course, I wish to learn from my research and apply in daily clinical care and the other way around and provide personalized medicine to all.
Mayo Clinic locations
Education
- 2008
ResidencyMaastricht University Medical Center
- 2003
Masters - Medical Studies Maastricht University Medical Center
- 1998
BAMS - Bachelor of Medical Studies Maastricht University Medical Center
- 1994
Bachelor - Health Sciences Maastricht University Medical Center
Activities and honors
Awards and honors
- 2025
Gold Research AwardDepartment of Family Medicine
- 2025
Dutch Pharmacogenomics Working Group, received an AwardEuropean Journal of Human Genetics
- 2025
Dutch Pharmacogenomics Working Group, received an AwardEuropean Journal of Human Genetics
- 2021
Best Block Bachelor Medicine LUMC G1CM Cel tot MolecuulLUMC Leids Universitair Medisch Cetrum
- 2021
Blended learning for application of fact knowledge Clinical Technology Patient CareLUMC/TU Delft
- 2019
Innovationfund LUMC/Boerhaave, Blended learning, oa Hemoglobinopathie, Cardiogenetica, Oncogenetica, Farmacogenetica in daily primary care practiceLUMC
- 2017
European Health Award Primary Care Genetics
- 2013
Nominated for Young investigators AwardEuropean Society of Human Genetics Conference
- 2013
PhD Researcher “Developing training in genetics/genomics for primary care health workers”, promotors Prof Dr M Cornel and GJ Dinant, co promotors Prof Dr C van der Vleuten and Dr L Henneman.Amsterdam UMC Location VUmc/MUMC Maastricht University Medical Center
- 2010
Putting plans into practice prize Center for Society and Genomics
- 1999
Student Science Award
"Aspects of preimplantation embryology and sex-related growth rate differences in mouse preimplantation embryos in the Ped fast and Ped slow strain in vivo"Maastricht University Medical School
Professional memberships
- 2026 - present
MemberSociety of Teachers of Family Medicine
- 2025 - present
MemberFamily Medicine iLab Executive Committee
- 2025 - present
MemberRST/KA Preventative Group
- 2025 - present
Expert panel memberCPIC CYP3A Gene Committee
- 2023 - present
MemberCIM Education IMPACT (Individualized Medicine Planning and Content Team)
- 2023 - present
MemberMayo Clinic, Department of Family Medicine Research Committee
- 2023 - present
MemberClinical Pharmacogenetics Implementation Consortium (CPIC)
- 2022 - present
MemberBiomedical Ethics Research Program
- 2022 - present
MemberMayo Clinic Pharmacogenomics Round Table
- 2022 - present
MemberMayo Clinic Pharmacogenomics Discovery & Translation
- 2022 - present
MemberGenetics in Primary Care
- 2022 - present
MemberCIPC Work Group
- 2022 - present
MemberThe Dutch College of General Practitioners
- 2022 - present
MemberMinnesota Medical Association
- 2022 - present
MemberNorth American Primary Care Research Group (NAPCRG)
- 2022 - present
MemberAmerican Academy of Family Physicians
- 2021 - 2022
NVMO Workgroup MemberLeiden University Medical Center (LUMC)
- 2021 - 2022
Network Innovative Medical Genomics Research Workgroup MemberLeiden University Medical Center (LUMC)
- 2021 - 2022
AI Education CAIRELab Workgroup MemberLeiden University Medical Center (LUMC)
- 2021 - present
MemberInternational Rare Diseases Research Consortium
- 2020 - present
Member PROGRESS Group meeting, UK, Pharmacogenomics Committee
- 2020 - present
International Rare Diseases Research Consortium MemberEuropean Commission and the US National Institutes of Health
- 2018 - present
MemberG2MC Flagship Family History working group
- 2017 - 2018
MemberWorkgroup NHG Standpunt Farmacogenetica
- 2016 - 2021
Committee Guideline development Psychiatry and pharmacogenetics MemberLeiden University Medical Center (LUMC)
- 2016 - 2020
MemberWorkgroup Richtlijnontwikkeling Psychiatrie en farmacogenetica
- 2016 - present
Special Interest Group: Primary Care Genetics MemberWorld Organization of Family Physicians
- 2015 - 2022
MemberOncogenetic Equip Advisory Group
- 2015 - present
MemberWorkgroup Pharmacogenetica
- 2014 - 2019
MemberPlatform Kwaliteitsverbetering Eerstelijnszorg Zeldzame Aandoeningen
- 2013 - 2018
MemberCommittee Prenatal care
- 2013 - 2017
MemberCommissielid Regionaal Centrum Prenatale Screening regio Zuid Oost Nederland
- 2013 - 2014
ContributorDutch College of General Practitioners (NHG) Cardiovascular Risk Management Guideline Committee
- 2011 - present
PresidentAlliantie CSG-NHG-Erfocentrum
- 2005 - 2010
MemberNetherland Associate Community Genetics Committee
- 2003 - 2004
President - Researchers ClubVUMC Department of GYN and OB
Publications
Research activities